These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35143992)

  • 1. Current nano-therapeutic approaches ameliorating inflammation in cancer progression.
    Rehman MU; Khan A; Imtiyaz Z; Ali S; Makeen HA; Rashid S; Arafah A
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):886-908. PubMed ID: 35143992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of nanotechnology for the treatment of cancer: Recent advances.
    Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
    Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation targeted nanomedicines: Patents and applications in cancer therapy.
    Praveen TK; Gangadharappa HV; Abu Lila AS; Moin A; Mehmood K; Krishna KL; Hussain T; Alafnan A; Shakil S; Rizvi SMD
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):645-663. PubMed ID: 35405339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface.
    Tracey SR; Smyth P; Barelle CJ; Scott CJ
    Biochem Soc Trans; 2021 Nov; 49(5):2253-2269. PubMed ID: 34709394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicines for Pediatric Cancers.
    Rodríguez-Nogales C; González-Fernández Y; Aldaz A; Couvreur P; Blanco-Prieto MJ
    ACS Nano; 2018 Aug; 12(8):7482-7496. PubMed ID: 30071163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advances in the application of nanomedicine in bladder cancer.
    Zhang C; Zhao J; Wang W; Geng H; Wang Y; Gao B
    Biomed Pharmacother; 2023 Jan; 157():114062. PubMed ID: 36469969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnologies for noninvasive measurement of drug release.
    Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
    Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in nanomedicine for metabolism-targeted cancer therapy.
    Da J; Di X; Xie Y; Li J; Zhang L; Liu Y
    Chem Commun (Camb); 2024 Feb; 60(18):2442-2461. PubMed ID: 38321983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine as a magic bullet for combating lymphoma.
    Mahajan S; Aalhate M; Guru SK; Singh PK
    J Control Release; 2022 Jul; 347():211-236. PubMed ID: 35533946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.
    Chakraborty K; Tripathi A; Mishra S; Mallick AM; Roy RS
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35638450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.
    Phillips MC; Mousa SA
    Nanomedicine (Lond); 2022 Mar; 17(6):405-421. PubMed ID: 35118878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of nanomedicines in lung cancer treatment.
    Norouzi M; Hardy P
    Acta Biomater; 2021 Feb; 121():134-142. PubMed ID: 33301981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.